Is There a Downside to Testosterone Replacement Therapy?

November 12, 2022

Side effects of testosterone replacement therapy

If you’re a man suffering from low testosterone, you may be wondering if it’s safe to take testosterone replacement therapy. The short answer is yes, but you should be aware of some side effects associated with the medication. These side effects can range from increased blood clotting to decreased sexual desire. You may also experience loss of bone density and increased risk of fractures. Some men may also experience fatigue and an increase in “bad” cholesterol.

Testosterone replacement therapy can cause side effects, but these side effects vary widely among individuals. The type of testosterone you take will have a direct effect on the side effects you experience. Certain types of testosterone may have more serious side effects than others. The most common side effect associated with testosterone replacement therapy is heart-related, but there are other risks as well.

Some of the most common side effects of testosterone replacement therapy include increased red blood cell counts and decreased “good” cholesterol and high-density lipoprotein levels. In addition, your blood pressure levels can increase, and doctors must closely monitor these factors to reduce the risk of heart attacks and other cardiovascular events.
Risks of deep vein thrombosis

In 2014, the FDA issued a warning about testosterone replacement therapy (TRT) and the risks of venous thrombosis. However, a new study suggests that there is no link between TRT and increased risk of DVT. However, there is still of venous thrombosis in rare sites.

The study included 30,572 men aged 40 years or older in one of the largest commercial health insurance programs in the United States. It identified 7,643 cases of VTE, which was defined as deep vein thrombosis or pulmonary embolism. Those men were treated with an intravascular vena cava filter or anticoagulant. The cases were matched to three controls on age, geographical region, and a history of prothrombosis. In all, the risk of DVT was 0.2%.

Although the risk of DVT was not increased with TRT, it was significantly higher among those with pathological hypogonadism compared with non-hoomen. The association was stronger in patients with late middle age and chronic disease.
Risk of polycythemia

Although there is no proven link between TRT and an increased risk of polycythemia, patients undergoing TRT should have their blood drawn regularly for the first two to three months of treatment. This blood draw will help physicians identify whether the treatment is effective and to monitor the patient’s hemoglobin and hematocrit levels. In addition, regular blood draws can help doctors determine whether the treatment is causing an increase in red blood cell production or not.

There are several causes of polycythemia, including a genetic mutation inside the bone marrow. Men who are undergoing TRT may experience an increased risk of developing polycythemia. Several methods are available to treat this condition, such as omega-3 fatty acids and daily aspirin. However, these methods do not typically replace therapeutic phlebotomy, which is the best option for those with polycythemia.

Testosterone levels are a strong risk factor for polycythemia. Higher testosterone levels are associated with a higher risk of developing polycythemia, as is greater age and smoking. Moreover, new post from Regenics with polycythemia are more likely to develop polycythemia when they are older, and continuous monitoring is important to ensure that polycythemia is treated accordingly.
Life-long treatment

Although testosterone replacement therapy (TRT) has been in the market for over two decades, the market is showing signs of a downturn. From 2001 to 2013, the number of prescriptions rose thirtyfold, thanks to marketing campaigns that touted the drug’s ability to help men regain their youthful fitness and sexual function. However, blog article about IV infusions at Regenics dropped by half in three years, as studies revealed TRT could increase the risk of heart disease. Also, in 2014, the Food and Drug Administration (FDA) ordered drug manufacturers to include a warning label on all prescriptions of TRT. This came after a study linked testosterone replacement therapy to venous thrombolism, a serious complication that can result in death.

In addition to raising the risk of heart disease, TRT also increases heart attack risk in men. However, some studies suggest that TRT can reduce the risk of heart attacks in men. A study of almost 44,000 men with low testosterone found that the drug decreased the risk of heart attack by 20 percent, but also raised the risk of stroke and heart disease.

18133 Ventura Blvd Suite C, Tarzana, CA 91356
(818) 515-0091